|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/53 | |
| G01N 33/567 | |||
| G01N 33/573 | |||
| A61K 31/435 |
| (11) | Number of the document | 2955520 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15173515.6 |
| Date of filing the European patent application | 2007-05-16 | |
| (97) | Date of publication of the European application | 2015-12-16 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-31 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 801089 P | 2006-05-16 | US | |
| 853631 P | 2006-10-23 | US |
| (72) |
LOCKHART, David, US
CASTELLI, Jeff, US
|
| (73) |
Amicus Therapeutics, Inc.,
1 Cedar Brook Drive, Cranbury, NJ 08512,
US
NATIONAL INSTITUTES OF HEALTH, 10 Center Drive, Bethesda, MD 20892-1260, US |
| (54) | TREATMENT OPTIONS FOR FABRY DISEASE |
| TREATMENT OPTIONS FOR FABRY DISEASE |